Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate the safety and tolerability of VLTS-589 compared with placebo, administered bilaterally to the lower extremities, in subjects with intermittent claudication an...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Valentis
NCT05132439 · Intermittent Claudication
NCT06782100 · Peripheral Vascular Diseases
NCT06656988 · Peripheral Vascular Diseases, Kidney Diseases
NCT04922762 · Peripheral Vascular Diseases
NCT04927156 · Intracranial Aneurysm, Brain Arterial Disease, and more
Cardiology Pc
Birmingham, Alabama
Arizona Heart Institute
Phoenix, Arizona
Access Clinical Trials-Cardiovascular Research
Beverly Hills, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions